Login / Signup

Efficacy and safety profile of nivolumab for Japanese patients with metastatic renal cell cancer.

Ryo FujiwaraKentaro InamuraTakeshi YuasaNoboru NumaoShinya YamamotoHitoshi MasudaAkihiro KawauchiKengo TakeuchiJunji Yonese
Published in: International journal of clinical oncology (2019)
Nivolumab has a relatively favorable efficacy and safety profile for Japanese metastatic renal cell cancer patients in clinical practice.
Keyphrases
  • single cell
  • clinical practice
  • cell therapy
  • squamous cell carcinoma
  • small cell lung cancer
  • papillary thyroid
  • young adults
  • bone marrow
  • lymph node metastasis